DDN webinar March 291200x200_V2

Register for the Webinar

Already registered?
Access the webinar here »

Proteolysis targeting chimeras (PROTACs) are small molecules capable of targeting disease-relevant proteins for degradation by the ubiquitin-proteasome pathway. The ability to target and destroy a specific protein-of-interest (POI) have made protein degrader molecules promising candidates for developing novel anticancer therapeutics. In this webinar brought to you by BPS Bioscience, Amar Natarajan and Guangrong Zheng will discuss the development and applications of PROTACs for cancer therapy.

Topics to be covered

  • PROTACs targeting hepatocyte growth factor receptor mutants
  • PROTACs to improve tissue selectivity


Amar Natarajan, PhD circle

Amar Natarajan, PhD
Professor, Eppley Institute for Research in Cancer and Allied Diseases
Co-leader, Targets Modulators and Delivery Program (TMDP)
Fred & Pamela Buffett Cancer Center
University of Nebraska Medical Center

Guangrong Zheng, PhD circle

Guangrong Zheng, PhD
Associate Professor
Department of Medicinal Chemistry
College of Pharmacy
University of Florida

Webinar Sponsor